Open Access Repository

Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study

Downloads

Downloads per month over past year

Shee, A, Prior, S ORCID: 0000-0001-5782-9141, Reeves, N, Smith, M and Luccisano, S 2019 , 'Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study' , International Journal of Diabetes and Endocrinology, vol. 4, no. 1 , pp. 6-12 , doi: 10.11648/j.ijde.20190401.12.

[img]
Preview
PDF
10...pdf | Download (656kB)

| Preview

Abstract

Aims: This study aims to identify differences in diabetes specific health related quality of life (HRQoL) inchildren and adolescents with type 1 diabetes mellitus (T1D) treated with three distinct types of intensive insulin therapymultiple daily injection (MDI), continuous subcutaneous insulin infusion (CSII) and flexible multiple daily injection (fMDI).Materials and Methods: This survey was conducted in north west Tasmania over a 6-month period, during quarterly clinicvisits. A well-known, reliable and validated survey tool -Paediatric Quality of life (PedsQL) Diabetes Module 3.0 was used tocapture information about the diabetic specific HRQoL in children and adolescents. The parent-proxy version of the forms wascompleted by the parents electronically using iSurvey application to secure information regarding their children’s diabetesrelated symptoms (11 items), treatment barriers (4 items), treatment adherence (7 items), worry (3 items) and communication(3 items). All de-identified information was downloaded into an excel spreadsheet and SPSS V24.0 for further analysis.Results: 34 parents completed the electronic data forms on iSurvey. There were no statistically significant differences inHRQoL among the CSII, MDI and fMDI groups as determined by one-way ANOVA in diabetes {F (2, 31) = 0.517, p = 0.601},treatment {F (2, 31) = 0.385, p = 0.684}, worry {F (2, 31) = 0.076, p = 0.927}, and communication {F (2, 31) = 0.672, p =0.518}. Conclusion: Although, the impact of T1D on the HRQoL in children and adolescents is higher than the childrenwithout T1D, it appears to be independent of the types of three intensive insulin therapy generally used- CSII, MDI and fMDI,suggesting type of insulin therapy may not be the major influencing factor for children’ quality of life as revealed in this firstof its kind study. A further study with higher number of participants and the additional impact of various glucose monitoringsystems on the HRQoL is highly recommended, which may influence the decision of right therapy suitable for the entirefamily.

Item Type: Article
Authors/Creators:Shee, A and Prior, S and Reeves, N and Smith, M and Luccisano, S
Keywords: Type 1 Diabetes Mellitus, Continuous Subcutaneous Insulin Infusion, Flexible Multiple Daily Injection, Multiple Daily Injection, Health Related Quality of Life, Paediatric Quality of life (PedsQL) Diabetes Module 3.0
Journal or Publication Title: International Journal of Diabetes and Endocrinology
Publisher: Science Publishing Group
ISSN: 2640-1363
DOI / ID Number: 10.11648/j.ijde.20190401.12
Copyright Information:

Copyright © 2019 The Authors. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) http://creativecommons.org/licenses/by/4.0/

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP